Review of T-2307, an Investigational Agent That Causes Collapse of Fungal Mitochondrial Membrane Potential.

Invasive infections caused by that are resistant to clinically available antifungals are of increasing concern. Increasing rates of fluconazole resistance in non- species have been documented in multiple countries on several continents. This situation has been further exacerbated over the last several years by , as isolates of this emerging pathogen that are often resistant to multiple antifungals. T-2307 is an aromatic diamidine currently in development for the treatment of invasive fungal infections. This agent has been shown to selectively cause the collapse of the mitochondrial membrane potential in yeasts when compared to mammalian cells. In vitro activity has been demonstrated against species, including , , and strains, which are resistant to azole and echinocandin antifungals. Activity has also been reported against species, and this has translated into in vivo efficacy in experimental models of invasive candidiasis and cryptococcosis. However, little is known regarding the clinical efficacy and safety of this agent, as published data from studies involving humans are not currently available.